There is clear genetic evidence for a central role for both of these enzymes in tumorigenesis: somatic mutations that target PTEN and the α catalytic subunit of PI3K (pi3kca) are frequent occurrences in human cancer, resulting in increased activity of the PtdIns(3,4,5)P3 signaling pathway [50]. The gene discussed is PTEN; the disease is cancer.